Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cleveland institutions to study CAR-T in Non-Hodgkin lymphoma

University Hospitals Cleveland Medical Center press statement

Key clinical point: A phase 1 trial of CAR T therapy is enrolling adult patients with NHL who have not responded to standard therapies.

Major finding: The trial site has the ability to manufacture the cells on site, saving patients time.

Study details: A phase 1 trial to evaluate safety.

Disclosures: The study will be funded by University Hospitals Seidman Cancer Center.

Read the article.

Citation:

University Hospitals Cleveland Medical Center press statement